✦ LIBER ✦

Pharmacological evaluation of combination therapy of P388 leukemia with cyclophosphamide and pyrimidinones

✍ Scribed by L.H. Li; T.L. Wallace; R.D. Hamilton; T.F. DeKoning

Book ID: 103624866
Publisher: Elsevier Science
Year: 1987
Tongue: English
Weight: 626 KB
Volume: 9
Category: Article
ISSN: 0192-0561
DOI: 10.1016/0192-0561(87)90108-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of acrylophenones and related

Evaluation of acrylophenones and related bis-Mannich bases against murine P388 leukemia

✍ Jonathan R Dimmock; Shirish A Patil; Donald M Leek; Robert C Warrington; Wei D F 📂 Article 📅 1987 🏛 Elsevier Science 🌐 French ⚖ 1017 KB

Activity of cladribine combined with cyc

Activity of cladribine combined with cyclophosphamide in frontline therapy for chronic lymphocytic leukemia with 17p13.1/TP53 deletion : Report From the Polish Adult Leukemia Group

✍ Tadeusz Robak; Jerzy Z. Blonski; Ewa Wawrzyniak; Joanna Gora-Tybor; Aleksandra P 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 1 views

Effective treatment of leukemia cutis wi

Effective treatment of leukemia cutis with combination of rituximab, cladribine, and cyclophosphamide in patient with B-cell chronic lymphocytic leukemia

✍ Aleksandra Batycka-Baran; Wojciech Baran; Justyna Dzietczenia; Grzegorz Mazur 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 138 KB

Combination effect of nevalbine (vinorel

Combination effect of nevalbine (vinorelbine ditartrate) with cisplatin against murine P388 leukemia and human lung carcinoma xenografts in mice

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 311 KB

Effect of finoptin on doxorubicin accumu

Effect of finoptin on doxorubicin accumulation in P-388 leukemia cells with induced resistance to a combination of finoptin and doxorubicin

✍ L. V. Moroz; F. B. Donenko; N. B. Borovkova; S. M. Sitdikova; A. O. Kabieva 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 248 KB

Combined cyclophosphamide, vincristine,

Combined cyclophosphamide, vincristine, procarbazine, and prednisone (copp) therapy of malignant lymphoma. Evaluation of 190 patients

✍ Marcos C. Morgenfeld; Alfredo Pavlovsky; Argimiro Suarez; Nilda Somoza; Santiago 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 626 KB

One hundred ninety patients who had advanced active Hodgkin's disease, lymphosarcoma, or reticulum cell sarcoma were treated with a combination of cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) given in a cyclical fashion every month. Complete remission was produced in 91 of 138